Knockdown of PIPKIα dramatically reduced CTGF and CYR61 levels in the triple-negative breast cancer cell lines MDA-MB-231 and MDA-MB-468 (Figs. 1A and EV1A). This evidence concerns the gene CCN2 and triple-negative breast carcinoma.